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Abstract
The genomes of Plasmodium parasites that cause malaria in humans, other primates, birds, and rodents all encode multiple
6-cys proteins. Distinct 6-cys protein family members reside on the surface at each extracellular life cycle stage and those on
the surface of liver infective and sexual stages have been shown to play important roles in hepatocyte growth and
fertilization respectively. However, 6-cys proteins associated with the blood-stage forms of the parasite have no known
function. Here we investigate the biochemical nature and function of two blood-stage 6-cys proteins in Plasmodium
falciparum, the most pathogenic species to afflict humans. We show that native P12 and P41 form a stable heterodimer on
the infective merozoite surface and are secreted following invasion, but could find no evidence that this complex mediates
erythrocyte-receptor binding. That P12 and P41 do not appear to have a major role as adhesins to erythrocyte receptors was
supported by the observation that antisera to these proteins did not substantially inhibit erythrocyte invasion. To
investigate other functional roles for these proteins their genes were successfully disrupted in P. falciparum, however P12
and P41 knockout parasites grew at normal rates in vitro and displayed no other obvious phenotypic changes. It now
appears likely that these blood-stage 6-cys proteins operate as a pair and play redundant roles either in erythrocyte invasion
or in host-immune interactions.
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Introduction
Malaria remains one of the most serious infectious diseases of
humanity. The disease is caused by the infection and destruction of
red blood cells and related sequelae by protozoan parasites
belonging to the genus Plasmodium. Of the four major species that
infect humans, Plasmodium falciparum and P. vivax are the most
widespread with P. falciparum being the most pathogenic and
responsible for an estimated 0.8–1.2 million deaths annually [1,2].
Infants are particularly susceptible to the disease because of less
developed immunity but if they survive repeated infections over
many years, a degree of protective but non-sterilising immunity
can be attained by several years of age. The development of
immunity offers hope that vaccine based strategies might be used
to reproduce or even generate superior levels of protection than
natural infection. One family of proteins, the 6-cys domain
proteins, are generating particular interest as vaccine candidates
because of their presence on the surface of different life stages.
The 6-cys domain proteins are so called because they contain
modules with six characteristic cysteines forming three intra-
molecular disulphide bonds between C1 and C2, C3 and C6, and
C4 and C5 [3–5]. There are at least nine members of the 6-cys
family encoded in each of the several Plasmodium genomes
sequenced to date that parasitise either primates, rodents or birds
[6–9]. Most family members contain two 6-cys modules, but up to
seven modules can be found in a single protein, in addition to
incomplete modules containing fewer cysteine residues [6,10].
About half of the 6-cys family members characterised to date
possess glycosylphosphatidylinositol (GPI) moieties that anchor
them to the outer leaflet of the plasma membrane, while those that
lack GPI-anchors presumably remain associated with the parasite
surface via interactions with other membrane proteins [8,10,11].
The first 6-cys protein discovered was cloned from a P. falciparum
blood-stage antigen COS expression library and was termed P12
after its clone number [12]. We have subsequently shown that P12
is GPI-anchored, a blood-stage antigen, and is expressed on the
merozoite [8,13]. We also identified a second blood-stage 6-cys
protein P41 and a third P38, that appears to be strongly expressed
throughout the life-cycle [8]. P41 is not GPI-anchored and
antibodies generated to the relatively long spacer region between
its two 6-cys domains indicated surface expression by immunoflu-
orescence microscopy [8]. P41 also could be a target of infected
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host humoral immune response since human malaria immune sera
recognise the spacer region [8].
The first two 6-cys proteins for which antibodies were shown to
inhibit progression through the lifecycle were P230 and P48/45.
These proteins are expressed on the surface of gametes and
antibodies to these inhibit the successful fusion of gametes in the
mosquito gut [14–17]. Gene knockout studies subsequently
showed that P48/45 and P230 were required by male gametes
to efficiently fuse with female gametes [18,19]. The knockout of
sporozoite stage 6-cys proteins, P36 and P36p, inhibited progres-
sion to blood-stage infection and the phenotype could be enhanced
by deleting both of the tandemly linked gene loci [20,21]. Loss of
these proteins caused the sporozoites to arrest during the
hepatocyte growth stage, perhaps as a result of failure of knockout
parasites to recognize hepatocytes, although the reason for growth
arrest has not been settled [20,21]. In the rodent malarial parasite
P. berghei, the failure of Dp36 and Dp36p sporozoites to progress to
blood-stage infection serves to protect mice from subsequent
challenge with wildtype parasites and thus dual knockout Dp36/
Dp36p parasites, if generated in P. falciparum, could act as live
attenuated vaccine [21–24].
In this report we investigate biochemical and functional aspects
of the P. falciparum blood-stage expressed 6-cys proteins P12 and
P41. We produced recombinant forms of P12 and P41 in both
bacterial and mammalian expression systems and generated
antibodies to these proteins for biochemical and functional studies.
Using mammalian expressed and parasite derived proteins,
interactions of the 6-cys with other proteins were examined and
revealed P12 and P41 form a heterodimer. The potential
functional role of P12 and P41 in erythrocyte invasion was
explored by assaying native and recombinant proteins for
erythrocyte binding activities, invasion-inhibition studies with
antibodies, as well as by genetically disrupting their genes and
assaying for growth defects.
Materials and Methods
Production of antibodies to recombinant P12 and P41 in
Escherichia coli
From P. falciparum genomic DNA p12 sequence corresponding
to H26 through to S321 was amplified so that the N-terminal
secretion signal sequence and C-terminal GPI-anchor signal
sequence were excluded. The p12 DNA fragment was ligated into
the SacII and NcoI sites of pASK45(+) (ABI) in frame with a N-
terminal Strep II tag and C-terminal 66His tag. A fragment of p41
excluding the N-terminal secretion signal sequence (K21 to S378),
was similarly amplified and ligated into the pASK45(+) as per p12.
After inducing the expression of the 6-cys proteins in E. coli with
0.2 mg/L anhydrotetracycline (as per manufacturer’s instructions)
the bacteria were harvested and their inclusion bodies containing
insoluble recombinant proteins were isolated as per [25]. The
inclusion bodies were solubilised in 8 M urea and the 66His
tagged proteins were purified over Ni2+-NTA agarose under
denaturing conditions (Qiagen). The proteins were then greatly
diluted and refolded in the presence of glutathione redox pair and
were further purified by anion exchange chromatography. P12
and P41 polyclonal rabbit sera and P12 mouse monoclonal
antibodies were produced at the Walter & Eliza Hall Institute
Monoclonal Antibody Facility.
Western blot analysis of recombinant proteins and
parasites
Recombinant E. coli produced P12 and P41 proteins were
fractionated by SDS-PAGE under non-reducing and reducing
(100 mM dithiothreitol) conditions followed by transfer onto
nitrocellulose membranes. These were probed with malaria
immune human IgG (5 mg/mL) followed by sheep anti-human
horseradish peroxidase (1/1000). Signal was detected on X-ray
film (Fuji) in the presence of chemiluminescence substrate (Pierce).
P. falciparum parasites were harvested at various stages through-
out the asexual blood-stage cell cycle. They were lysed in 0.09%
saponin to remove excess hemoglobin and were then solubilised in
1% Triton X-100 in PBS with complete protease inhibitor cocktail
(Roche). After removing insoluble material by centrifugation
(180006g) the parasite lysates were mixed with SDS sample buffer
prior to SDS-PAGE under non-reducing and reducing conditions.
After transfer onto nitrocellulose membrane parasite proteins were
probed with rabbit anti-P12 and anti-P41 IgGs (10 mg/mL)
followed by goat anti-rabbit IRDyeTM 800 (1/5000, Rockland).
Mouse monoclonals such as that for P12 (20 mg/mL) were
detected with goat anti-mouse IRDyeTM 700 (1/5000). The
secondary antibodies were imaged with a LI-COR Odyssey FC
instrument.
Parasite culturing
P. falciparum strains 3D7 and CS2 were maintained in
continuous culture as per [26]. To produce late stage protein
extracts of parasites, infected erythrocytes (32–40 hrs post
infection) were first isolated from uninfected erythrocytes by
passage through magnetized columns (Miltenyi). The purified
schizonts were then cultured at 37uC in RPMI media without
Albumax until about half the schizonts had ruptured after which
the remaining intact schizonts were pelleted by centrifugation
(5006 g) to produce 40–48 hr schizont extracts. The supernatant
was then pelleted to enrich for the smaller merozoites (20006 g).
To produce culture supernatant, the magnet-purified schizonts
were incubated overnight until all had released merozoites that
had subsequently shed their surface coats. The culture supernatant
was clarified by pelleting the merozoites followed by concentration
of the supernatant proteins through 10 kDa cut-off spin concen-
trators (Millipore).
Immunofluorescence microscopy
Late schizonts and merozoites were fixed with 4% paraformal-
dehyde/0.0075% glutaraldehyde as described previously [27].
The cells were labelled with mouse and rabbit antibodies specific
to MSP1 (4H9/19 [28]; 17b6), P12, and P41 as indicated and
corresponding secondary antibodies Alexa Fluor 488 goat anti-
rabbit IgG and Alexa Fluor 568 goat anti-mouse IgG (1/2000,
Molecular Probes). The images were captured using Zeiss
AxioObserver Z1 fluorescence microscope and analysed with
ImageJ software.
Mammalian expression and avidity-based extracellular
interaction screening (AVEXIS)
To express P12 and P41 in a mammalian expression system, the
regions of the genes encoding the predicted ectodomain fragments
were chemically synthesized (Geneart AG, Germany) so that their
codons were optimized for expression in human cells. In addition,
any potential N-linked glycosylation sequons were mutated (N-X-
S/T to N-X-A) to prevent inappropriate glycosylation and an
exogenous signal peptide was used and cloned N-terminal to a rat
Cd4 domain 3 and 4 (Cd4d3/4) tag using flanking NotI and AscI
restriction sites as described [29,30]. Proteins were produced as
secreted 66His tagged recombinant proteins using HEK293E cells
and purified using Ni2+-NTA resin, essentially as described [31].
AVEXIS assays were performed as described [31].
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Size exclusion and surface plasmon resonance (SPR)
Binding of recombinant P12 and 41 (recP12 and recP41
respectively) to form a heterodimer was examined by column shift
assay. Equimolar amounts of recP12-Cd4d3/4-6H (150 mg at
2.0 mg/mL) and recP41-Cd4d3/4-6H (180 mg at 3.5 mg/mL)
were co-incubated for 1 hr at 37uC in phosphate buffer
(containing 250 mM imidazole). Following incubation samples
were centrifuged for 10 minutes at 180006 g at 4uC prior to
filtration through 0.2 mm Acrodisc 13 mm Syringe Filters (Pall
Corporation). This material underwent gel filtration chromatog-
raphy using a Superdex 200 10/300 GL column (GE Healthcare)
in PBS on an A¨KTA Purifier (GE Healthcare). recP12-Cd4d3/4-
6H (300 mg) and recP41-Cd4d3/4-6H (360 mg) were also subject-
ed to gel filtration (Superdex 200 10/300 GL) independently to
determine their individual retention volumes as a point of
comparison with the heterodimer.
Biophysical binding analysis was performed by surface plasmon
resonance using a T100 instrument (BIAcore). Briefly, proteins
were captured on streptavidin-coated sensor chips (Biacore, GE
Healthcare) by a C-terminal enzymatically biotinylatable tag
‘‘bio’’ as described [31]. Approximately 150RU of biotinylated rat
Cd4d3/4 (tag alone) was captured in the flow cell used as a
reference and approximate molar equivalents of recP12-Cd4d3/4-
bio or recP41-Cd4d3/4-bio immobilised in the other flow cell.
Purified recP12-Cd4d3/4-6H or recP41-Cd4d3/4-6H proteins
were resolved by gel filtration just prior to use in SPR experiments
to remove small amounts of protein aggregates which are known
to influence kinetic binding measurements. Increasing concentra-
tions of purified proteins were injected at high flow rates (100 mL/
min) to minimise rebinding effects for kinetic studies or at 10 mL/
min for equilibrium analysis. Both kinetic and equilibrium binding
data were analysed in the manufacturer’s evaluation software.
Equilibrium binding measurements were taken once equilibrium
had been reached using reference-subtracted sensorgrams. All
experiments were performed at 37uC.
Immunoprecipitations
Rabbit pre-immune, anti-P12, and anti-P41 IgGs were firstly
immobilised on Protein G agarose as per manufacturer’s
instructions (Pierce). Parasite lysates prepared as above were
incubated with IgG-immobilised Protein G agarose overnight at
4uC. The unbound lysates were collected for further analysis and
the resins were then washed with 1% Triton X-100 in PBS to
remove unbound proteins. Bound proteins were eluted off the
resins using 0.1 M glycine (pH 2.8) solution. The pH of the
samples were adjusted to 7 using 1 M Tris-HCl buffer (pH 9.0)
and were prepared in non-reducing sample buffer for western blot
analysis. For protein identification by LC-MS/MS sequencing,
samples were prepared in reducing sample buffer for SDS-PAGE.
Protein gels were stained with GelCode Blue Stain reagent as per
manufacturer’s instructions (Pierce).
Chemical crosslinking
Schizont-stage parasites were subjected to magnet purification as
described earlier. Samples were divided into 5 equal aliquots and
resuspended in 5 mL PBS with complete protease inhibitor cocktail
(Roche). Dithiobis(succinimidylpropionate), DSP (Thermo), pre-
pared in dimethyl sulfoxide (Sigma) was added to the final
concentration of 0 mM, 62.5 mM, 125 mM, 250 mM, and
500 mM, and parasites were crosslinked for 30 minutes at room
temperature. Parasite material was subsequently pelleted and
crosslinking reactions were quenched for an additional 30 minutes
at room temperature by the addition of 5 mL of quenching solution
(25 mM Tris-HCl, 120 mM NaCl, pH 7.5). The crosslinked
samples were washed and subsequently lysed by 0.09% saponin.
They were then solubilised in 1% Triton X-100 in PBS and
prepared for western blot analysis in non-reducing sample buffer.
Erythrocyte binding assay and depletion assay
Erythrocyte binding assays were carried out as previously
described with slight modifications [32]. Briefly, 250 mL of culture
supernatant containing invasion ligands was mixed with 50 mL of
packed fresh erythrocytes for 30–60 minutes at room temperature.
The RBCs were separated from supernatant by spinning through
400 mL of dibutyl phthalate (Aldrich) at 120006 g for 30 seconds.
Proteins bound to the erythrocytes were eluted by incubating with
10 mL of 1.6 M NaCl in PBS at room temperature for 10 minutes.
Eluted proteins were obtained after 4 minutes of centrifugation at
120006 g and mixed with equal volume of 26 non-reducing
sample buffer. The eluates were analysed by western blotting as
described above. Depletion assays were also performed to
determine the RBC-binding activity of P12/P41. Culture super-
natant was serially incubated five times with batches of uninfected
erythrocytes at 20% hematocrit. Each incubation was performed
at room temperature for an hour. Aliquots of supernatant from
each round were analysed by western blotting.
Double crossover gene knockouts
To generate knockout constructs for 3D7 and CS2 parasites, 59
and 39 sequences of p12 and p41 genes were amplified from
parasite genomic DNA and cloned into pCC1 plasmid [33]. The
59 flanks of p12 and p41 were cloned into the plasmid via SacII/
SpeI restriction sites. The 39 flanks of both genes were cloned into
the pCC1 plasmid via EcoRI/AvrII sites. Primers used to generate
the knockout plasmids are described in supplementary information
(Table S1). These knockout plasmids were transfected into 3D7
and CS2 parasites and the double crossover knockout parasites
were selected as outlined in [33]. Clonal lines of knockout parasites
were achieved by limiting dilution.
Southern blot and PCR analyses
Genomic DNA of knockout parasites were digested with
restriction enzymes, XbaI/AvaII for Dp12 parasites and Hin-
dIII/SphI for Dp41 parasites, and transferred to a nylon
membrane after electrophoresis. The membrane was probed with
dioxygenin (DIG)-labelled 59 flank and 39 flank, amplified as
described above, followed by chemiluminescent detection per
manufacturer’s instructions (Roche). Specific primers were also
designed to confirm homologous recombination in knockout
parasites by PCR (supplementary information; Table S2).
Growth measurement and invasion inhibition assay
Synchronous cultures of 3D7, Dp12, Dp41, and Dp36 parasites
were adjusted to 1% parasitemia and were subsequently diluted
100,000 fold in duplicate. They were continuously cultured for 6
cycles, when one of the parasite lines grew back up to
approximately 1% parasitemia, and all parasites were counted
and calculated for the amplification rates. One-way ANOVA
analysis was performed using Prism software (GraphPad).
The invasion inhibition assay was performed as previously
described [34]. Briefly, filtered purified merozoites were mixed with
uninfected RBCs at appropriate parasitemia and hematocrit.
Prepared cultures were added to a 96 well U-bottom plate in the
presence of purified rabbit anti-P12 and anti-P41 IgGs made to E.
coli recombinant proteins at 2 mg/mL final concentration. Non-
immune rabbit IgG was used as a non-inhibitory control. All
samples were run in duplicate. The 96-well plates were placed in
Biochemical and Functional Analysis of P12 and P41
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humidified gassed chamber as per standard culture condition for an
hour and the cultures were then washed twice with culture medium
to remove the antibodies. The samples were prepared for flow
cytometry analysis 40 hours later by resuspension in 100 mL of PBS
with 10 mg/mL ethidium bromide (EtBr, Bio-Rad). They were
stained for one hour prior to centrifugation, removal of the
supernatant and resuspension in 200 mL of PBS. Parasitemia was
measured on a Becton Dickinson FACSCalibur flow cytometer
using a 488 nm laser for excitation of EtBr stained (Fl–2) parasites.
Samples were analysed using FlowJo software (Tree Star Inc.) by
first gating for intact erythrocytes with side scatter and forward
scatter parameters, and subsequently determining the positive cells
in FL2 channel. Invasion inhibition by the anti-P12 and anti-P41
antibodies was calculated as percentages of pre-immune rabbit IgG.
Invasion inhibition assays using rabbit polyclonal anti-P12 and
anti-P41 IgGs generated against the HEK293E expressed proteins
were performed as described in [35].
Results
Expression of recombinant P12 and P41 in E. coli and
HEK293E mammalian cells
A p12 DNA fragment amplified from P. falciparum genomic
DNA, excluding the N-terminal secretion signal sequence and C-
terminal GPI-anchor signal sequence (H26 to S321, Fig. 1A), was
expressed in E. coli to produce a fusion protein with an N-terminal
Strep II tag and C-terminal 66His tag. A fragment of P41,
excluding the N-terminal secretion signal sequence (K21 to S378,
Fig. 1A), was similarly expressed. Inclusion bodies containing
insoluble fusion proteins were isolated from E. coli and were
solubilised in 8 M urea and the fusion proteins were purified over
Ni2+-NTA agarose under denaturing conditions. The proteins
were then highly diluted and refolded in the presence of
glutathione redox pair and were further purified by anion
exchange chromatography. Equal amounts of the recombinant
6-cys proteins were fractionated by SDS-PAGE under reducing
and non-reducing conditions. Western blots of these were probed
with pooled malaria immune human serum and for both P12 and
P41 bands of the expected size were detected (37 and 45 kDa,
respectively, Fig. 1B). The P12 and P41 proteins were then used to
immunise rabbits to produce polyclonal antibodies. Mice were also
immunised with both proteins, however a monoclonal antibody
was only obtained to P12.
P12 and P41 C-terminally tagged with rat Cd4d3/4 followed by
66His were expressed in HEK293E mammalian cells (Fig. 1C; left
panel). The purified recombinant P12 and P41 were soluble,
migrated at the expected sizes by SDS-PAGE and were highly
pure (Fig. 1C; right panel). Rabbit polyclonal antibodies were also
raised against these mammalian recombinant P12 and P41.
P12 and P41 are expressed in schizont-stage parasites
and are shed into the culture supernatant
The antibodies raised to E. coli expressed P12 and P41 detected
proteins of the expected size in the western blots of parasite
proteins (Fig. 2A). The non-reduced parasite proteins showed
greater mobility than reduced proteins attesting to the disulphide
bonding in the former. Interestingly, the difference in mobility was
not as pronounced in recombinant versions of P12 and P41 and
whether this reflects improper folding is unknown. However, the
proteins appear to have generated effective antibodies. Parasite
proteins with invasion-related functions are usually made late in
the 48 hr cell cycle and become incorporated into developing
merozoites. To ascertain if this was the case with P12 and P41,
parasites were harvested at 8–10 hour intervals post invasion and
extracted proteins were subjected to SDS-PAGE and western
blotting under reducing and non-reducing conditions. P12 and
P41 were first detected in the trophozoite stage, 30–40 hrs post
invasion (HPI) and the proteins reached their peak expression in
schizont stage, 40–48 HPI (Fig. 2A). Both proteins were faintly
detected in 12–20 and 20–30 HPI stage parasites, though this may
have been due to low level contamination with older parasites
since the published transcriptome data for p12 and p41 does not
indicate transcription at this time [36,37]. Moreover, P12 and P41
were also detected in culture supernatant suggesting that these
proteins are shed from the merozoite surface (Fig. 2A). We note
that P41 and GAPDH migrate as a single band in reduced samples
and as two bands in non-reduced samples, and consider the latter
to be caused by the electrophoretic conditions rather than extra
post-translational processing. Of note, two forms of P12 were
present in parasite samples under both reducing and non-reducing
conditions while in culture supernatant only the smaller form was
detected (Fig. 2A). This likely indicates a form of proteolytic
cleavage is responsible for the shedding of P12 from the merozoite
surface, possibly occurring in near proximity to the GPI-anchor, as
similarly occurs for merozoite surface protein 1 (MSP1) [38]. The
protease subtilisin 2 is known to cleave several proteins from the
merozoite surface and is therefore possibly responsible for P12
cleavage [38]. In the immature parasite samples a degree of
proteolytic cleavage of P12 appears to have occurred during
parasite lysate preparation, despite the inclusion of protease
inhibitors (Fig. 2A).
P12 localises to the merozoite surface
We have previously shown that P41 resides in the parasitophor-
ous vacuole space of the segmented schizont and on the merozoite
surface by immunolabelling. GFP-tagging of P12 indicates that it is
also surface localised [8]. However, the localisation of native P12
has not been previously confirmed given that GFP-tagging can
result in incorrect trafficking [39]. Rabbit P12 anti-serum was
employed here to probe the location of the native protein.
Schizonts and ruptured merozoites adhering to the surface of
erythrocytes were examined since although they do not appear to
be invading, are still likely to retain their adhesive surface coats.
We have found that native P12 is located in the parasitophorous
vacuole space of segmented schizonts and it is present on the
surface of merozoites (Fig. 2B). In addition, P12 shows an
increased concentration towards the darkly contrasting apical
region visualized by phase contrast microscopy, which is different
from the established surface marker MSP1 (Fig. 2B, white arrows).
Recombinant P12 and P41 form a stable heterodimer
Because P41 does not possess a GPI-anchoring sequence or
predicted transmembrane domain, this raises the possibility that
P41 interacts with another protein(s) on the merozoite surface.
Since the GPI-anchored P12 shares the same expression profile
and localisation as P41, we hypothesised that they may be
interacting partners as has been reported for other 6-cys family
members, P230 and P48/45, on the gametocyte surface [11].
Heterodimerisation of recP12-Cd4d3/4-6H and recP41-Cd4d3/
4-6H was first established by means of a column shift assay
following co-incubation in PBS at 37uC for an hour. The retention
volume of the co-incubated 6-cys proteins was compared to that of
the individual proteins by gel filtration chromatography. The co-
incubated proteins eluted as a major peak at a retention volume of
13.2 mL and a less abundant shoulder possibly representing
monomeric protein (Fig. 3A, green line). The individual proteins
were resolved with retention volumes of 14.69 mL (recP12-
Cd4d3/4-6H) and 14.34 mL (recP41-Cd4d3/4-6H). When plot-
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ted on a curve of molecular weight standards (linear log MW
curve), the elution volumes of recP12-Cd4d3/4-6H and recP41-
Cd4d3/4-6H corresponded to proteins with an apparent molec-
ular weight of ,90 kDa and ,105 kDa respectively. The major
peak resolved for co-incubated material eluted at a retention
volume corresponding to an apparent molecular weight of
,180 kDa indicative of heterodimer formation. It is worthy to
note that estimation of molecular weight by gel filtration is
confounded by factors including buffer type, interactions with the
chromatographic medium, particle size distribution and ultimately
only fractionates proteins on the basis of their Stokes radius, not
molecular weight.
Surface plasmon resonance was then used to characterise the
physical properties of the recP12-Cd4d3/4-6H and recP41-
Cd4d3/4-6H interaction, and established an equilibrium dissoci-
ation constant (KD) for the complex of 0.3160.03 mM (Fig. 3B; a).
We also measured the kinetic properties of the interaction which
was calculated as 1.336610560.004 M21 s21 for the association
rate constant (ka) and 0.0212260.00007 s
21 for the dissociation
rate constant (kd) (Fig. 3B; b). To determine whether P12 and P41
could interact homophilically, we independently injected purified
recP12-Cd4d3/4-6H or recP41-Cd4d3/4-6H over the same
proteins that had been immobilised using a C-terminal biotin
tag on streptavidin-coated sensor chips. When 2.5 mM of recP12-
Cd4d3/4-6H (solid bar) was injected over the chip, an interaction
was observed with recP41-Cd4d3/4-bio (blue line), but not
recP12-Cd4d3/4-bio (red dotted line) (Fig. 3B; c). The reciprocal
experiment, where 2.5 mM of recP41-Cd4d3/4-6H was injected,
confirmed the interaction between the hetero-species (Fig. 3B, d).
There was no evidence that either recP12 or recP41 are able to
interact with themselves in a homophilic interaction.
P12 and P41 form a heterodimer on the merozoite
surface
Having established heterodimerisation of recombinant P12 and
P41, we investigated whether this held true for the native proteins
by performing co-immunoprecipitation experiments with 6-cys
antibodies crosslinked to Protein G agrose resin. Immunoprecip-
itations were performed on 3D7 schizont lysates using rabbit anti-
P12 IgG. Eluted precipitates were fractionated by SDS-PAGE and
stained with colloidal Coomassie. The most strongly staining
bands were excised from the gel and proteins identified by LC-
MS/MS sequencing (Fig. 4A). In addition to a band of ,32 kDa
corresponding to P12, a second larger species which co-eluted in
low pH glycine was identified as P41 indicating P12 and P41 are
likely to be associated in late stage parasites. Other species eluted
under more stringent conditions were identified by LC-MS/MS,
but proved to contain abundant parasite proteins not derived from
the merozoite surface (e.g. ER localised HSP70 BIP), and are
therefore likely to represent non-specific interactions (Fig. 4A). P41
could also be clearly detected in western blots of anti-P12
immunoprecipitates (Fig. 4B). Reciprocal experiments immuno-
precipitating P41 also co-purified P12, but other surface proteins
such as EBA175 and MSP1 could not be detected (Fig. 4B).
Further immunoprecipitation experiments identified no other
specific interacting partners (data not shown). We therefore
conclude that native P12 and P41 are interacting partners.
To establish whether the native P12/P41 complex represents a
single heterodimer or a higher order complex, we stabilized the
complex with a reduction-sensitive chemical crosslinker DSP.
Crosslinking demonstrated a single P12 and P41 heterodimer,
since no larger complex formation was observed (Fig. S1). We also
determined that, in the absence of P41, P12 does not homo-
dimerize in the parasite, consistent with the gel filtration and
surface plasmon resonance studies (Fig. S1). The crosslinked
samples also served to explore potential weak or transiently
interacting partners of the P12/P41 dimer that could not remain
associated under conventional immunoprecipitation conditions.
While MSP1, MSP9, and SERA5 were identified as associating
with the P12/P41 dimer, we consider this interaction is likely a
consequence of random crosslinking possibly due to dense surface
packing of these proteins (Fig. S2).
Figure 1. Recombinant P12 and P41 fusion proteins produced in Escherichia coli and HEK293E cell expression system. (A) Diagram of
P12 and P41 showing regions (black lines) that were expressed in E. coli. Secretion signal sequences are in white, protein spacer regions in yellow, 6-
cys domains are in red and the glycosylphosphatidyl inositol signal sequence is in black. (B) A western blot of recombinant reduced and non-reduced
P12 and P41 expressed in E. coli probed with pooled malaria immune human serum. Molecular mass protein markers are indicated on the left. (C) P12
and P41 expressed recombinantly C-terminally fused to domain 3 and 4 of rat Cd4 (green) followed by 66His (blue) (left) in HEK293E cells.
Recombinant proteins were expressed as soluble proteins of expected sizes (Coomassie-stained gel, right).
doi:10.1371/journal.pone.0041937.g001
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Native P12 and P41 from culture supernatants do not
bind to erythrocytes
Since both P12 and P41 were localised to the surface of the
merozoite, we investigated whether they serve as a parasite
invasion ligand binding to an erythrocyte receptor in the same
manner as other merozoite surface proteins such as EBA175.
Culture supernatant containing native P12 and P41 was used in
preference to recombinant proteins in the event that a functional
binding complex is dependent upon additional interacting proteins
that remain unidentified. Culture supernatant was incubated with
uninfected erythrocytes and cells were centrifuged through oil
(dibutyl phthalate), washed, and eluted with a high salt solution as
has previously been performed successfully for other ligands [40].
Western blot analysis however detected no binding for P12 and
P41 in contrast to EBA175, a known invasion ligand that binds to
Glycophorin A (Fig. 5A).
The oil-based erythrocyte binding assay is considered of
reasonable stringency given the multiple washing steps to remove
weakly interacting proteins. Consequently a second less stringent
approach was adopted whereby aliquots of uninfected erythrocytes
were serially incubated with a single sample of culture supernatant
to deplete its erythrocyte binding proteins. Upon comparison to
the starting material and the mock incubated material (a,b
respectively, Fig. 5B) each round of erythrocyte incubation did
not substantially deplete P12 and P41. As a positive control,
EBA175 was significantly depleted to ,10% of its original amount
following 5 rounds of erythrocyte incubation (Fig. 5B). The
comparatively weaker-binding MSP1-42 fragment of MSP1,
which has been demonstrated to bind to heparin sulphate-like
sugars on the erythrocyte surface, was also depleted to,30% of its
original amount [41]. While a slight depletion of P12 and P41
following 5 rounds of exposure to fresh erythrocytes may be due to
extremely weak interactions with the erythrocyte surface, it is more
likely attributable to small dilution effects at each binding step. We
therefore conclude that since the heterodimeric form of P12/P41
shed from the merozoite surface does not appear to bind fresh
erythrocytes the complex probably does not have a direct
erythrocyte-binding role during invasion.
Figure 2. P12 and P41 are expressed in schizont-stage parasites and are shed into the culture supernatant. (A) Equal amounts of total
protein from parasites harvested at different times throughout the asexual blood-stage cell cycle were subjected to SDS-PAGE in non-reducing and
reducing conditions. Blots of these proteins were probed with rabbit IgGs raised to recombinant P12 and P41 (10 mg/mL) expressed in E. coli and
demonstrated maximum expression of P12 and P41 in late stage parasites. Blots were also probed with rabbit anti-GAPDH (kindly supplied by
Professor Leann Tilley) to ensure equal loading of parasite material from the various time points. (LR = late ring, ET = early trophozoite,
T = trophozoite, ES = early schizont, Sc = schizont) (B) Localisation of P12 was explored by immunofluorescence assays. Schizonts and merozoites were
fixed and labelled with mouse anti-MSP119 (10 mg/mL) and rabbit IgG to P12 (50 mg/mL) followed by Alexa Fluor 488 goat anti-rabbit and Alexa Fluor
568 goat anti-mouse secondary antibodies IgG. P12 was found to localise to the parasitophorous vacuole in schizonts and on the merozoite surface
upon comparison with MSP119. Interestingly, P12 exhibited concentrated apical localisation on the merozoite surface (white arrow) similar to the
published localisation of P41 [8]. The representatives of schizonts and merozoites are shown.
doi:10.1371/journal.pone.0041937.g002
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Figure 3. Recombinant P12 and P41 form a heterodimer. (A) The recP12-Cd4d3/4-6H (blue line), recP41-Cd4d3/4-6H (red line) and the co-
incubated proteins (green line) were resolved on a Superdex 200 10/300 GL column. Upon co-incubation, a single peak was observed at a lower
retention volume than that observed for the individual proteins, corresponding in size to a P12/P41 heterodimer. (B) Biochemical analysis of the
recombinant P12/P41 interaction by surface plasmon resonance. (a) Equilibrium dissociation constant (KD) for P12/P41 interaction. Serial dilutions of
recP41-Cd4d3/4-6H were injected through flow cells containing Cd4d3/4 (as a reference) and recP12-Cd4d3/4-bio captured on a streptavidin-coated
sensor chip until equilibrium had been reached (see inset). Reference-subtracted binding data were plotted as a binding curve and an equilibrium
dissociation constant calculated using non-linear regression fitting of a simple Langmuir binding isotherm to the data (solid line). (b) Kinetic data for
the P12/P41 interaction. Serial two-fold dilutions of 3.6 mM purified recP41-Cd4d3/4-6H were injected at high flow rates (100 mL min21) over recP12
and a reference flow cell. Sensorgrams showed excellent fits to a simple 1:1 binding model (shown in red) and were used to derive association (ka)
and dissociation (kd) rate constants. (c, d) P12 and P41 do not interact homophilically. (c) Injection (solid bar) of purified 2.5 mM recP12-CD4d3/4-6H
over recP41-Cd4d3/4-bio (blue line) and recP12-Cd4d3/4-bio (red dotted line) immobilised on a streptavidin-coated sensor chip. The reciprocal
experiment using purified P41 is shown in (d).
doi:10.1371/journal.pone.0041937.g003
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P12 and P41 are not essential for blood-stage
development
Different subsets of 6-cys proteins are expressed at different
stages of the parasite life cycle, and deletion of the genes encoding
for 6-cys proteins in sexual and liver stages resulted in dramatic
phenotypes. This suggests a broad role for this family of proteins in
regulating parasite development [18–21,23,24]. To test the
hypothesis that P12 and P41 perform a similar function in
blood-stage parasites, we performed p12 and p41 genetic deletions
using a homologous recombination strategy outlined in Fig. 6A.
The mutagenesis strategy involved using a positive drug selection
gene (hDHFR) to produce transfected parasite lines carrying the
integration plasmid and then a negative drug gene (cytosine
deaminase) favouring the removal of the plasmid backbone and
the disruption of the coding sequences of p12 and p41 by insertion
of the positive drug selection cassette via double recombination
[33]. Laboratory parasite lines 3D7 and CS2 were transfected with
the gene-knockout plasmids and following positive/negative drug
selection, gene replacement of the p12 and p41 loci were
confirmed by Southern blot analysis (Fig. 6A, Fig. S3A). Southern
blots indicated the Dp41 parasites were of a mixed population
including wildtype parasites therefore necessitating the generation
Figure 4. Native P12 and P41 interact as a heterodimer. (A) A schizont lysate of 3D7 parasites in 1% Triton X-100 in PBS was subjected to
immunoprecipitation using rabbit anti-P12 IgG crosslinked to Protein G agarose. Bound proteins were serially eluted off the beads by 0.1 M glycine,
0.1 M glycine with 1 M NaCl, and 2% SDS. Eluates, along with the unbound material were analysed by SDS-PAGE followed by colloidal Coomassie
staining. Proteins immunoprecipitated by anti-P12 IgG were excised from the polyacrylamide gel and evaluated by LC-MS/MS sequencing. P41,
HSP70, 60 s ribosomal protein, and BSA were identified, however given its co-elution in glycine, P41 was the most likely binding partner of P12. (B)
The P12 and P41 interaction was also confirmed by western blotting of immunoprecipitated material using pre-immune (PI), anti-P12, and anti-P41
rabbit IgG coupled Protein G agarose. The 1% Triton X-100 soluble (S) and insoluble (I) parasite extracts were included as controls. Blots were also
probed with anti-EB175 and anti-MSP119 sera to demonstrate the specificity of the P12/P41 interaction.
doi:10.1371/journal.pone.0041937.g004
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of clonal lines by limiting dilution. Genomic DNA (gDNA) was
then extracted from several of the clones and a PCR was used to
confirm in which lines deletion of p12 and p41 had occurred. This
strategy involved amplification across both 59 and 39 crossover
regions with specific primers (Fig. 6A, Fig. S3B). Protein extracts
from Dp12 and Dp41 parasites were then prepared for SDS-PAGE
and western blotting confirming the selected mutant lines no
longer expressed their respective 6-cys proteins (Fig. 6B). Likewise,
immunofluorescence microscopy of mutant schizont stage para-
sites confirmed loss of protein expression in vacuole space
surrounding the developing merozoites (Fig. 6C).
Dp12 and Dp41 parasites did not display altered growth
or invasion phenotypes
Analysis of Dp12 and Dp41 parasite lines established that neither
gene is essential for blood-stage growth. However, other possible
phenotypes such as reduced growth rate due to less efficient
merozoite maturation and invasion were investigated. We
therefore compared the growth rates of the Dp12 and Dp41
parasites with the similarly constructed Dp36 parasite line that
includes the same hDHFR selection marker [24]. P36, also a 6-cys
protein, is exclusively expressed in sporozoites and is therefore
highly unlikely to have a role in blood-stage growth. All three
deletion lines, made in a 3D7 strain background, were adjusted to
1% parasitemia, diluted 100,000 fold and grown until the fastest
growing line had amplified again to ,1%. Parasitemias of all
strains were then measured and amplification rates per cell cycle
were calculated (Fig. 7A). 3D7, Dp12 clone 1, Dp41 clone 1, and
Dp36 clone 4.9 parasites had growth rates of 6.7760.29,
6.6760.36, 6.5660.10, and 7.0260.21 fold per cell cycle,
respectively. Parasite lines were subjected to one-way ANOVA
analysis which showed no significant difference in growth rate
across all lines.
P12 and P41 antisera do not substantially inhibit parasite
growth
It has been established that invasion ligands do not necessarily
require direct binding to erythrocyte receptors in order to have an
invasion related function. Such is the case for AMA1, which binds
to the RON complex injected into the erythrocyte surface by the
merozoite [42,43]. The AMA1-RON complex forms part of the
tight junction through which the parasite moves to invade its new
host cell [42,43]. Since antibodies raised to AMA1 are some of the
most potent inhibitors of P. falciparum invasion known, we decided
to test invasion inhibition by anti-P12 and anti-P41 IgGs, made to
E. coli recombinant proteins. Relative to pre-immune control IgG,
anti-P12 and anti-P41 IgGs only demonstrated invasion inhibition
by 15–20% at a relatively high concentration of 2 mg/mL
(Fig. 7B). Rabbit polyclonal IgG raised to the mammalian recP12-
and recP41-Cd4d3/4-6H fusion proteins were similarly ineffective
at inhibiting invasion of 3D7 and Dd2 parasite lines (Fig. 7C).
While these antibodies were able to block the P12/P41 interaction,
they failed to substantially disrupt the heterodimer once formed
(Fig. S4).
Discussion
Because 6-cys family members play important roles in gamete
fertilization and hepatocyte infection, we hypothesised that the
merozoite 6-cys proteins P12 and P41 may play a similarly
important role in merozoite invasion. While we demonstrate that
these proteins form a stable heterodimer and are localised to both
the merozoite surface and apical region, and so are appropriately
positioned for a role in invasion, several lines of evidence fail to
demonstrate any significant role for these proteins in this capacity.
Firstly, we examined the role of P12 and P41 in invasion by
performing erythrocyte-binding assays. Despite adopting several
experimental approaches we failed to detect erythrocyte binding
using native heterodimer present in culture supernatant. Also, in
using the mammalian-expressed recombinant P12/P41 heterodi-
mer we did not detect specific binding of the heterodimer to any
parasite or erythrocyte protein in lysates of whole infected
schizonts (data not shown). We found the absence of a detectable
binding partner surprising since proteins related to the 6-cys
family, namely the homo-dimeric SAG proteins from Toxoplasma
gondii, are predicted to bind sugars in a groove formed between the
paired N-terminal 6-cys domains [44]. The crystal structures of
various SAG-like proteins have now been solved and reveal that
the N-terminal grooves are heterogeneous in shape and charge
indicating their carbohydrate ligands may be quite diverse [45–
47]. Until very recently the only structures available for 6-cys were
Figure 5. Native P12 and P41 from culture supernatant do not
bind to erythrocytes. (A) Invasion supernatant (S/N) containing P12
and P41 was incubated with uninfected erythrocytes and bound
proteins were eluted from the erythrocytes once centrifuged through
oil. EBA175, a known erythrocyte binding protein, bound to the
erythrocytes as expected; however, P12 and P41 did not. (B) Lack of
binding of P12 and P41 to erythrocytes was also confirmed via an
erythrocyte binding protein depletion assay to test for weak
interactions between P12/P41 and RBCs. The relative amounts of target
protein in starting material and in mock incubation (i.e. no erythrocytes)
are shown in lanes marked a & b, respectively.
doi:10.1371/journal.pone.0041937.g005
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Figure 6. The genes for P12 and P41 can be disrupted and are therefore not essential for parasite growth. (A) Diagram of plasmid and
strategy for disrupting p12 and p41. A positive drug selection gene encoding a human dihydrofolate reductase (hDFHR) gene is flanked by sequences
derived from the P12/P41 genes that will facilitate integration into the locus by double homologous recombination. To eliminate parasites in which
integration has not occurred, a negative drug selection cytosine deaminase gene is included to remove the plasmid backbone from the transfected
parasite population. (B) Western blots indicate that Dp12 and Dp41 lines do not express proteins corresponding to their respective disrupted genes.
(C) Immunofluorescence microscopy of Dp12 and Dp41 and parental 3D7 parasites probed with rabbit anti-P12 and anti-P41 IgGs in addition to the
merozoite surface marker MSP1 mAb indicate absence of protein expression in the mutants aside from minor cross-reactivity.
doi:10.1371/journal.pone.0041937.g006
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Figure 7. Genetic knockout growth analysis and invasion inhibition assays suggest a non-essential role for P12/P41 in vitro. (A)
Growth rates of Dp12 and Dp41 mutants were measured. All parasite lines, 3D7, Dp12 clone 1, Dp41 clone 1, and Dp36 clone 4.9, were adjusted to 1%
parasitemia and were subsequently diluted 100,000 fold in duplicate. Parasites were cultured for 6 cycles, until 1% parasitemia was achieved for one
of the four parasite lines, then parasites were counted to calculate their rate of amplification. As shown in the graph (mean with SD), 3D7, Dp12 clone
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modelled on the crystal structure of the SAG1 protein [44].
Arredondo et al. have now solved the NMR structure of the
membrane proximal 6-cys domain of P12 in P. falciparum and
confirmed the previous predicted structure [5]. A structure for full-
length recombinant P12 protein could not be derived, however
our production of highly pure recP12 and recP41 capable of
heterodimerising now offers the prospect of solving the whole
structure of a Plasmodium 6-cys heterodimer.
Next, we attempted to establish if antibodies to P12 and P41
were capable of inhibiting merozoite invasion of erythrocytes
which would serve to validate the potential of these proteins as
vaccine targets. At a relatively high IgG concentration of 2 mg/
mL, weak invasion inhibitory activity of 10–20% was observed for
both antibodies raised to E. coli expressed P12 and P41 relative to
pre-immune IgG. At lower antibody concentrations invasion
inhibitory activity was far less pronounced (data not shown).
Moreover, combining the antibodies to both antigens offered no
synergistic activity greater than the additive contributions of each
individual antibody (data not shown). By comparison, the invasion
inhibitory activity of polyclonal antibodies towards AMA1 is quite
potent, (up to 50% at 0.5 mg/mL) possibly interfering with AMA1
binding to RON2 ablating successful tight junction formation
[48,49].
The same level of poor invasion inhibitory activity was also
evident with antibodies raised to the P12 and P41 fusion proteins
expressed in mammalian cells. Based on their ability to form
discrete heterodimers, it is likely that these fusion proteins are in
their correct conformation and should generate antibodies to
native epitopes (Fig. 3A). Antibodies to the mammalian expressed
P12 and P41 fusion proteins were effective at preventing
heterodimer formation if incubated with their respective monomer
prior to co-incubation of the two proteins (Fig. S4). These
antibodies were however incapable of disrupting the already
formed heterodimer. This suggests that antibody-mediated
disruption of the heterodimer is unlikely to occur in vivo. We
interpret the low level of invasion inhibition observed with anti-
P12 and anti-P41 IgGs raised against protein expressed in E. coli is
non-specific, possibly due to coating of the merozoite surface
rather than the inhibition of a specific invasion related function.
Thirdly, we undertook a genetic approach to shed light on the
function of P12 and P41 by deleting their genes and assaying for
changes in growth rates and invasion pathways. It has been
established that deletion of certain parasite invasion ligands can
trigger a compensatory increase in the expression of alternative
invasion ligands coupled by a switch in invasion pathways. For
example, deletion of EBA175 in the W2mef strain leads to the up-
regulation of reticulocyte binding homolog 4 (Rh4) expression and
a subsequent switch from a sialic acid dependent to a sialic acid
independent invasion pathway [50]. Such changes in the parasite’s
invasion pathway can be detected by measuring differences in the
rate of invasion into enzymatically treated erythrocytes. This
results in the removal of specific erythrocyte receptors used by the
parasite for a given invasion pathway. To assess whether a similar
scenario was occurring with respect to Dp41, its growth was
compared with the CS2 parental line in trypsin-, chymotrypsin-
and sialidase-treated erythrocytes. Over the assayed growth
period, no substantial difference in parasite amplification was
detected between the Dp41 and CS2 (data not shown), suggesting
that no significant change in invasion phenotype occurs in the
absence of P41. Furthermore, we could not detect any changes in
growth rates of either Dp12 or Dp41 parasites in vitro (Fig. 7). This
was somewhat surprising given the extensive phylogenetic
conservation of P41 and P12 orthologs across the Plasmodium
genus coupled with the aforementioned observations by others
that deletion of 6-cys proteins expressed at other life stages leads to
dramatic phenotypic changes. Deletion of p47, p48/45 and p230 in
Plasmodium berghei leads to dramatic declines in gamete fertilization
[19]. In P. bergehi and P. falciparum deletion of p36 and p36p leads to
growth arrest during hepatocytic development even though the
sporozoites appear to invade hepatocytes normally [20,21,24].
Admittedly though, not all deleted 6-cys genes produce detectable
phenotypes since the asexual stage 6-cys member, p38, was
successfully deleted in P. berghei without apparent growth changes
[19].
It is interesting to note that some P41 remains detectable in
samples prepared from saponin-lysed Dp12 parasites despite the
loss of its membrane anchored binding partner (Fig. 6B). Although
some P41 is also found in the parasitophorous vacuole fraction of
Dp12 parasite, we can only assume the P41 that remains on the
parasite surface must be interacting with other merozoite surface
proteins. It would be interesting to identify these other partners
even though our initial attempt here to identify these partners was
unsuccessful.
Perhaps one reason why a phenotype was not observed for the
blood-stage expressed 6-cys null mutants resides in the extensive
time these mutants have to adapt in vitro. Months of culturing are
required to establish such mutants and in this time the completion
of 30–40 blood-stage cycles may very well allow for compensatory
changes which could serve to restore normal growth. This
circumstance is in stark contrast to the deletion mutants of 6-cys
proteins expressed at other life stages which are examined
phenotypically in the first cycle of that particular stage. In this
regard it is interesting to note that while P36 and P36P knockout
lines display dramatic phenotypes in hepatocyte invasion, in both
cases breakthrough parasites are observed even in this single cycle.
Hence, the phenotype is not completely penetrant and it may
stand to reason that multiple passages of breakthrough parasites
through hepatocytes results in a strongly adapted P36 and P36P
knockout line having no discernable hepatocyte development
phenotype from the wildtype line. This hypothesis though remains
conjecture and ultimately conditional knockdown of p12 and p41
expression is needed to examine whether phenotypes can be
observed in the first blood-stage cycle.
The fact that the majority of merozoite surface proteins have no
known function despite decades of study indicates the difficulties
associated with this area of research. MSP1 is the merozoite
1, Dp41 clone 1, and Dp36 clone 4.9 had similar growth rates of 6.77, 6.67, 6.56, and 7.02 fold per cycle, respectively, which is not statistically different
(p = 0.4753, one-way ANOVA analysis). (B) Invasion inhibition assay indicated that antibodies to E. coli recombinant P12 and P41 only weakly inhibited
merozoite invasion. Purified merozoites were incubated with rabbit polyclonal anti-P12 or anti-P41 IgGs at the final concentration of 2 mg/mL in the
presence of uninfected erythrocytes. New infections were measured by counting parasitemia 40 hrs later by flow cytometry. Using rabbit pre-
immune IgG as a control, the results indicated that anti-P12 and anti-P41 antibodies could inhibit parasite invasion by 15–20%. Total parasitemias and
schizont-stage parasite populations were counted. (C) Invasion inhibition assays using antibodies generated against the HEK293E expressed P12 and
P41 failed to demonstrate invasion inhibitory activity. Late trophozoite stage parasites were incubated with rabbit polyclonal anti-P12 or anti-P41
antibodies either independently or in combination. Final concentrations are shown. Parasites were cultured for 24 hours, and re-invasion was
measured by flow cytometry. All assays were performed in triplicate, and invasion efficiency calculated comparatively with parasites incubated in the
absence of antibodies. No significant difference in invasion efficiency was observed at any concentration of IgG.
doi:10.1371/journal.pone.0041937.g007
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surface protein for which we have the most advanced functional
knowledge, namely the native protein has been proposed to bind
to heparin-like molecules on erythrocyte surface [41]. A fragment
of MSP1, MSP133, was also recently suggested to have an
immunomodulatory role in the human host [51]. The MSP3 null
mutant displays reduced invasion rates but this has provided little
information on the precise role of this protein [52]. Genetic
deletion of other MSP genes has been successful but again has
provided little functional information with the parasites exhibiting
a modest or no growth delay [53–55]. Of those MSPs that appear
to be refractory to genetic deletion, this simply indicates they are
probably essential for blood-stage growth but provides very little
information on their possible functions either [54].
Given the involvement of other 6-cys family members in
processes of recognition and adhesion, the possibility remains that
the P12/P41 complex plays a non-essential role in in vitro culture.
Such a role would be difficult to detect by the approaches reported
herein and perhaps requires new techniques to capture a low-
affinity and presumably transient interaction between the P12/
P41 complex and its putative erythrocyte receptors possibly in
their native membrane bound forms. It is also possible that P12
and P41 bind to erythrocyte types other than the O-type
normocytes used in these experiments and it would be worthwhile
in the future repeating these experiments in other blood types
especially reticulocytes which support rapid parasite growth [56].
Alternatively, the P12/P41 protein complex may bind to host
proteins to facilitate host immunomodulatory roles, functions not
detected by our in vitro approaches. Given that P12 and P41 are
apparently exclusively expressed in the blood-stage, and are
evolutionarily conserved throughout the Plasmodium genus, they
would seem likely to play an important biological function. The
fact that this function was not revealed by any of the biochemical
or functional assays described here is perhaps indicative of the
ultimate limitations of working with P. falciparum in an in vitro
model culture system. However, this work has clearly established
that these proteins are likely to function as a heterodimeric
complex, and therefore future functional studies should focus on
this form.
Supporting Information
Figure S1 Crosslinking experiment confirms the native
P12/P41 heterodimer formation. Proteins from magnet-
purified schizonts were crosslinked with various concentrations of
DSP since achieving optimal crosslinking is empirical. Following
schizont lysate extraction, crosslinked proteins were separated by
SDS-PAGE and underwent western blot analysis. When probed
for P12, a species of approximately 70 kDa was detected in the
crosslinked samples corresponding to a predicted single P12/P41
heterodimer in CS2 parasites (upper panel). This heterodimeric
species was not detected in the absence of DSP whereas
monomeric P12 could be detected in all the samples. When
probed with anti-P41 two bands were detected in the 70 kDa
range (lower panel). To establish which species corresponded to
the P12/P41 dimer, Dp41 parasites in a CS2 background were also
crosslinked and following SDS-PAGE were western blotted and
probed with anti-P41 antibodies. The smaller of the two ,70 kDa
bands detected by anti-P41 antibodies in the parental CS2 line
disappeared in the Dp41 parasites indicating this band represented
the heterodimer.
(TIF)
Figure S2 Identification of binding partners of P12/P41
complex. Crosslinked and non-crosslinked schizont lysates of
CS2 and Dp41 CS2 parasites were immunoprecipitated with
rabbit anti-P12 and anti-P41 antibodies immobilised on Protein G
beads. Prior to fractionation by SDS-PAGE DSP crosslinks were
reduced by treatment with dithiothreitol and folllowing electro-
phoresis bands unique to the crosslinked sample were excised from
the colloidal Coomassie-stained polyacrylamide gels. Proteins were
identified by LC-MS/MS sequencing. Bands excised contained
the highly abundant merozoite surface/parasitophorous vacuole
proteins MSP1, MSP9 and SERA5.
(TIF)
Figure S3 Southern blotting and PCR show the success-
ful disruption of p12 and p41 genes. (A) Genomic DNA of
wildtype 3D7, Dp12 3D7, and Dp41 3D7 were extracted and
Southern blots performed as outlined in the experimental
procedures. Probing with both 59 flank and 39 flank, DNA from
Dp12 and Dp41 parasites following 2 rounds (2cyc+5-FC) and 3
rounds (3cyc+5-FC) of drug cycling revealed DNA fragments of
expected sizes corresponding to parasites that had undergone
double crossover recombination. This is indicative of the deletion
of p12 and p41. P41-null parasites were found to be of a mixed
population including a subpopulation of wildtype parasites.
Consequently Dp41 clones were achieved by limiting dilution.
(B) The extracted gDNA from 3D7, Dp12 clone 1, and Dp41 clone
1 was also used to confirm homologous recombination by PCR
with double crossover specific primers. All primer pairs yielded
expected results for either 59 or 39 integration sites of P12-null and
P41-null parasites.
(TIF)
Figure S4 The anti-recP12 and anti-recP41 antibodies
are capable of blocking the P12/P41 interaction but
cannot disrupt the heterodimer once formed. The
interaction between recP12 and recP41 was detected using the
AVEXIS method. (A) The pentameric b-lactamase-tagged recP12
prey was incubated in the presence of increasing concentration of
anti-recP12 antibody before being presented to the monomeric
biotinylated recP41 bait immobilised on a streptavidin-coated
microtitre plate. The interaction was detected by hydrolysis of the
b-lactamase substrate nitrocefin forming a product that absorbs at
485 nm. (B) The reciprocal experiment in which the anti-recP41
antibody was pre-incubated with the recP41 prey could also block
binding to the recP12 bait. (C) Neither anti-recP12 nor anti-
recP41 had the capacity to destabilise the formed recP12-recP41
complex. recP12 (red) or recP41 prey (blue) was presented to its
respective bait, prior to the addition of varying concentration of
anti-recP12 or anti-recP41, respectively to the formed complex.
No decrease in absorbance was observed. All experiments were
performed in triplicate; error bar = SD.
(TIF)
Table S1 Primers used to generate knockout plasmids.
(DOC)
Table S2 Primers used to validate homologous recom-
bination in the knockout parasites by PCR.
(DOC)
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